Apart from transforming growth factor beta (TGF-β) [38], IL-6 has been documented to be involved in lung cancer EMT via signal transducer and activator of transcription 3 (STAT3) [39], Notch [40–41] pathway. This evidence concerns the gene IL6 and lung carcinoma.